Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent

This publication has 50 references indexed in Scilit:

• Engineered VaginalLactobacillusStrain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-N
  Antimicrobial Agents and Chemotherapy, 2006
• Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes
  Journal of Virology, 2006
• Site-specific Discrimination by Cyanovirin-N for α-Linked Trisaccharides Comprising the Three Arms of Man8 and Man9
  Journal of Molecular Biology, 2002
• Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers
  AIDS, 2000
• Solution structure of cyanovirin-N, a potent HIV-inactivating protein
  Nature Structural & Molecular Biology, 1998
• Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
  The Journal of Experimental Medicine, 1997
• Analysis of Sequence Requirements for Biological Activity of Cyanovirin-N, a Potent HIV(Human Immunodeficiency Virus)-Inactivating Protein
  Biochemical and Biophysical Research Communications, 1997
• The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells
  Immunology Today, 1994
• INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITRO
  The Lancet, 1985
• An unusual lectin from stinging nettle (Urtica dioica) rhizomes
  FEBS Letters, 1984